Pack Health Publishes Research Confirming Impact for Patients with Type 2 Diabetes in JMIR Diabetes

Industry: Healthcare

12-week results across HbA1c cohorts include lowered BMI, increased overall mental and physical health scores, and reductions in diabetes distress.

Birmingham, AL (PRUnderground) June 9th, 2021

Leading patient engagement platform Pack Health today announced the publication of their recent study, “The influence of baseline A1c on digital health coaching outcomes for adults with type 2 diabetes: A real-world retrospective cohort study” in the Journal of Medical Internet Research (JMIR) Diabetes. The study aims to examine the impact of  digital health coaching outcomes by baseline hemoglobin A1c to better understand which populations may experience the greatest clinical and psychosocial benefit from the intervention.

Digital health coaching is a common diabetes self-management support strategy and has been linked to positive mental and physical health outcomes. However, the relationship between baseline risk and outcomes has yet to be evaluated in a real-world setting. For this study, the digital health coaching program included patient-centered lifestyle and psychosocial support through phone calls, texts, and emails with a dedicated Pack Health Advisor. Individuals participated for a total of 12 weeks with pre and post data collection. 

“Digital health coaching solutions are rapidly scaling across the US to address the complex needs of individuals living with type 2 diabetes,” says Megan Martin, MPH, Director of Strategic Partnerships and Programs at Pack Health. “Data from previous studies illustrate the tremendous potential of these accessible solutions to both reach and positively impact patients between clinical visits,” Martin added.

With 81% of participants having a reported baseline A1c of greater than 7%, 12-week results across A1c cohorts include lowered BMI, increased overall mental and physical health scores, and reductions in diabetes distress. Individuals in the high-risk A1c cohort (i.e., A1cs greater than 9%) reported the greatest reduction margin at -2.28 points.

“This real-world study builds on existing knowledge to improve our understanding of potential outcomes and, specifically, which patients may experience the greatest benefit,” says Dhiren Patel, PharmD, CDCES, BC-ADM, Senior Vice President of Medical Affairs at Pack Health. “We hope that our findings will lay the foundation for future clinical trials to better inform targeted referral strategies and ensure these services get to those who need it the most.”

About Pack Health

Pack Health is an evidence-based patient engagement platform that helps change health behaviors to close gaps in care and improve outcomes. Pack Health comprehensively addresses chronic conditions, comorbidities, social determinants, and barriers. The model is proven to drive results across industries, including life sciences, health plans, and research. For more information, visit www.packhealth.com.

In 2022, Pack Health was acquired by Quest Diagnostics, the nation’s leading provider of diagnostic information services. Pack Health is part of Quest’s Extended Care portfolio of services designed to facilitate access to care beyond traditional healthcare settings. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States.

Pack Health is intended to be an aid for people to gain insights into ways to help improve their general health and well-being.

Learn more at https://www.packhealth.com/.

Contact: Brittney Vigna, Director of Marketing, Pack Health, brittney@packhealth.com

Print Friendly, PDF & Email

Press Contact

Name
Brittney Vigna
Phone
855-255-2362
Email
Contact Us
Website
https://packhealth.com/

Image Gallery